BioSpace News Archive

Drug Development

Karuna’s KarXT Drug Could Signal New Hope for Schizophrenia - Updated

Karuna Therapeutics released results from the Phase III EMERGENT-2 trial showing that KarXT, its lead candidate, can strongly reduce symptom severity in schizophrenia patients.

August 8, 2022
·
3 min read
·
Tristan Manalac
A Question of Life and Death: Yale Scientists Bring Pig Organs Back to Life

If replicated in humans, this technology could prolong organ health during major surgeries and improve the availability of donor organs.

August 8, 2022
·
3 min read
·
Tristan Manalac
Deals

Pfizer Doubles Down on Sickle Cell Disease with $5.4B Global Blood Therapeutics Buy

Pfizer announced Monday that it is acquiring the hematology-focused company for $5.4 billion in order to bolster its presence in the multi-billion dollar rare disease market.

August 8, 2022
·
3 min read
·
Alex Keown
Policy

PhRMA CEO Calls Passage of Inflation Reduction Act a “Tragic Loss for Patients”

The Inflation Reduction Act, which is expected to have wide-ranging implications for the pharmaceutical industry, will still need to go to the House of Representatives.

August 8, 2022
·
4 min read
·
Mark Terry
Drug Development

Despite Slowing Disease Progression, Amgen’s Lung Cancer Studies Show High Liver Toxicity

Results from two Amgen studies on Lumakras for lung cancer showed its ability to slow disease progression, although combining it with immunotherapy increased the risk for TRAEs.

August 8, 2022
·
3 min read
·
Vanessa Doctor, RN
Business

Do Q2 Results and Increased M&A Indicate a Recovery for Biotech?

A recent report predicts multiple acquisitions are set to be announced in the second half of the year, particularly by companies that have strong revenue streams from COVID-19 products.

August 8, 2022
·
3 min read
·
Alex Keown
Drug Development

Tufts’ Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure Rates

Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts’ Ken Getz about possible reasons and solutions.

August 8, 2022
·
5 min read
·
Gail Dutton
Pediatric Psoriasis Market Size Worth USD 21.38 billion By 2027, According to Latest Study by Emergen Research

The global pediatric psoriasis market was valued at USD 9.76 billion in 2019 and is expected to reach USD 21.38 billion by the year 2027, at a CAGR of 10.3%.

August 8, 2022
·
6 min read
Tonic-Clonic Seizure Market Analysis till 2030 - Biggest Driving Factors For Industry Growth

Forecast to 2030,’ thoroughly examines the Tonic-Clonic Seizure industry to provide essential data & information for the targeted readers.

August 8, 2022
·
5 min read
West Syndrome Market Is Moving Towards with Tremendous Growth By 2030

Forecast to 2030,’ thoroughly examines the West Syndrome industry to provide essential data & information for the targeted readers.

August 8, 2022
·
5 min read